Collaborations & Alliances

Horizon, Ubiquigent Enter Ubiquitin Research Pact

Will combine X-MAN cell lines with ubiquitin-related drug discovery services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Horizon Discovery Group plc has entered into a collaboration agreement with Ubiquigent Ltd. for the use of Horizon’s X-MAN cell lines as part of its ubiquitin system focused drug discovery services. This collaboration aims to provide more complete research solutions to support commercial and academic partners with ubiquitin system focused drug discovery programs.    The ubiquitin system offers new drug discovery target opportunities across multiple therapeutic areas. It provides access to drug...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters